Impact of NRAS mutations for patients with advanced melanoma treated with immune therapies

Douglas B. Johnson*, Christine M. Lovly, Marisa Flavin, Katherine S. Panageas, Gregory D. Ayers, Zhiguo Zhao, Wade T. Iams, Marta Colgan, Sarah De Noble, Charles R. Terry, Elizabeth G. Berry, A. John Iafrate, Ryan J. Sullivan, Richard D. Carvajal, Jeffrey A. Sosman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

88 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of NRAS mutations for patients with advanced melanoma treated with immune therapies'. Together they form a unique fingerprint.

Medicine & Life Sciences